NEW YORK STOCK EXCHANGE, INC. · WST
-1.17% · -$4.29 · Vol 1.5M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Life Sciences Tools & Services
$362.31
Card
Relationship Map

Follow $WST

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $WST by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Analyst data unavailable at compute time
WST
West Pharmaceutical Services Inc
Sun Sep 20 · market closed · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Sun Sep 20 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is WST moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading WST catalysts
About West Pharmaceutical Services Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
1973
Employees
11K
Country
US

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$366.59
Day high
$366.86
Day low
$359.52
Previous close
$366.60
52W high
$366.86
-1.24% from high
52W low
$230.95
97% of range
Market cap
$25.5B
Beta
0.16
Shares out
70.4M
Volume
1.5M
2.76× rel vol
Avg volume
527.4K
VWAP
$362.34
Price history computed in-house
1W
+4.64%
1M
+2.61%
3M
+9.89%
1Y
+42.17%
YTD
+31.68%
SMA 50 $349.24 · above
SMA 200 $297.46 · above
52W position 97%

WST overview

Loading financial statements
Loading WST Form 4 filings
Public disclosures

Congress activity in WST

No receipt-qualified Congressional disclosure is present for WST in the cached public ledger.

Federal contracts

WST contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for WST in this window.
Lobbying spend

WST lobbying filings, year to date.

Registered lobbying filings matched to West Pharmaceutical Services Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for WST in this window.
Loading news for WST
Analyst ratings
Sovereign unlock shows live analyst consensus for WST.
Options
Sovereign unlock shows live options positioning for WST.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.